阵发性睡眠性血红蛋白尿症、自身免疫性溶血性贫血与遗传性球形红细胞增多症溶血特征比较
比较1998年1月至2017年4月108例经典型PNH、127例AIHA与172例HS患者的临床表现和溶血特征。PNH患者Ret%明显低于AIHA和HS,LDH明显高于两者;HS患者TBIL、脾大和胆囊结石比例明显高于AIHA和PNH。综合评估Ret%、TBIL、LDH、脾大及胆囊结石五项溶血特征有助于三者倾向性判断。
要点
- PNH患者Ret%[6.70%(0.14%~22.82%)]明显低于AIHA[14.00%(0.10%~55.95%)]和HS[11.83%(0.60%~57.39%)](P<0.001)。
- PNH患者LDH[1 500(216~5 144)U/L]明显高于AIHA[487(29~3 516)U/L]和HS[252(132~663)U/L](P<0.001)。
- HS患者TBIL[79.3(11.2~244.0)μmol/L]明显高于AIHA[57.6(7.6~265.0)μmol/L]和PNH[26.2(4.6~217.7)μmol/L](P<0.001)。
核心结论
- 综合评估Ret%、TBIL、LDH水平、脾大及胆囊结石这五项溶血特征,可以清晰地倾向性判断PNH、AIHA和HS,并为下一步进行特异性实验室检查确诊提供可靠的诊断思路。
- 这种综合评估简单、实用、有效,具有重要的临床意义。
研究设计与样本
- 比较1998年1月至2017年4月108例经典型PNH患者、127例AIHA患者与172例HS患者的临床表现和溶血特征。
主要发现
- PNH患者Ret%[6.70%(0.14%~22.82%)]明显低于AIHA患者[14.00%(0.10%~55.95%),z=7.101,P<0.001]和HS患者[11.83%(0.60%~57.39%),z=8.477,P<0.001]。
- 轻度贫血时PNH与AIHA患者Ret%水平差异无统计学意义,AIHA患者Ret%低于HS患者[7.63%(1.87%~29.20%)对11.20%(3.31%~22.44%),z=-2.165,P=0.030];中、重度贫血时PNH患者Ret%水平均显著低于AIHA和HS患者。
- HS患者TBIL水平为79.3(11.2~244.0)μmol/L,显著高于AIHA患者[57.6(7.6~265.0)μmol/L]与PNH患者[26.2(4.6~217.7)μmol/L](z值分别为5.469、-2.165,P值均<0.001)。
- HS患者TBIL超过4倍正常值上限比例(64.1%)明显高于AIHA患者(37.7%,χ(2)=19.896,P<0.001)和PNH患者(4.6%,P<0.001)。
- PNH患者LDH水平为1 500(216~5 144)U/L,显著高于AIHA患者[487(29~3 516)U/L]与HS患者[252(132~663)U/L](z值分别为-9.556、-11.518,P值均<0.001);79.1%的PNH患者LDH>1 000 U/L,明显高于AIHA患者(13.0%,χ(2)=93.748,P<0.001)和HS患者(0,P<0.001)。
关键数值与推荐
- PNH患者Ret%[6.70%(0.14%~22.82%)]明显低于AIHA患者[14.00%(0.10%~55.95%),P<0.001]和HS患者[11.83%(0.60%~57.39%),P<0.001]。
- HS患者TBIL[79.3(11.2~244.0)μmol/L]显著高于AIHA患者[57.6(7.6~265.0)μmol/L]与PNH患者[26.2(4.6~217.7)μmol/L](P值均<0.001)。
- PNH患者LDH[1 500(216~5 144)U/L]显著高于AIHA患者[487(29~3 516)U/L]与HS患者[252(132~663)U/L](P值均<0.001)。
- HS患者TBIL超过4倍正常值上限比例(64.1%)明显高于AIHA患者(37.7%,P<0.001)和PNH患者(4.6%,P<0.001)。
- 79.1%的PNH患者LDH>1 000 U/L,明显高于AIHA患者(13.0%,P<0.001)和HS患者(0,P<0.001)。
临床怎么用
- 综合评估Ret%、TBIL、LDH水平、脾大及胆囊结石这五项溶血特征,可以清晰地倾向性判断PNH、AIHA和HS,并为下一步进行特异性实验室检查确诊提供可靠的诊断思路。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To determine the valuable hemolytic characteristics in differential diagnosis of paroxysmal nocturnal hemoglobinuria (PNH), autoimmune hemolytic anemia (AIHA) and hereditary spherocytosis (HS). Method: The clinical and hemolytic characteristics of 108 PNH patients, 127 AIHA patients and 172 HS patients diagnosed from January 1998 to April 2017 were compared. Results: ①Reticulocyte percentage (Ret%) of PNH patients [6.70% (0.14%-22.82%)] was significantly lower than that of AIHA [14.00%(0.10%-55.95%), P<0.001] and HS patients [11.83%(0.60%-57.39%), P<0.001]. The Ret% in PNH patients were significantly lower than those in AIHA and HS patients at the same levels of anemia, except for in mild anemia between PNH and AIHA patients. However, when comparing the Ret% between AIHA and HS patients, there was significant difference only in mild anemia [7.63%(1.87%-29.20%)% vs 11.20%(3.31%-22.44%), z=-2.165, P=0.030]. ②The level of TBIL in HS patients was significantly higher than that in AIHA and PNH patients [79.3 (11.2-244.0) μmol/L vs 57.6 (7.6-265.0) μmol/L, z=5.469, P<0.001; 79.3(11.2-244.0) μmol/L vs 26.2(4.6-217.7) μmol/L, z=-2.165, P<0.001], and the proportion of HS patients with TBIL more than 4 times the upper limit of normal (ULN) (64.1%) was significantly higher than that of AIHA (37.7%, χ(2)=19.896, P<0.001) and PNH patients (4.6%, P<0.001). ③The LDH level of PNH patients was significantly higher than that of AIHA and HS [1 500 (216-5 144) U/L vs 487 (29-3 516) U/L, z=-9.556, P<0.001; 1 500 (216-5 144) U/L vs 252 (132-663) U/L, z=-11.518, P<0.001], and the proportion of PNH patients with LDH more than 1 000 U/L (79.1%) was significantly higher than that of AIHA patients (13.0%, χ(2)=93.748, P<0.001) and HS patients (0, P<0.001). ④Splenomegaly occurred in 43.5% of PNH patients, including 16.0% with severe splenomegaly. In contrast, the occurrence of splenomegaly was 98.6% in AIHA patients and 100.0% in HS patients (P<0.001), and 63.0% of AIHA patients (P<0.001) and 90.4% of HS patients (P<0.001) were with severe splenomegaly. ⑤The prevalence of cholelithiasis in HS patients was up to 43.1%, significantly higher than that in AIHA patients (10.5%, P<0.001) and PNH patients (2.9%, P<0.001). Conclusion: The comprehensive assessment of the five hemolytic characteristics is simplified, practical and efficient, with great clinical significance, providing specific indicators for differential diagnosis and efficient approach for making further work-up. 目的: 确定在阵发性睡眠性血红蛋白尿症(PNH)、自身免疫性溶血性贫血(AIHA)与遗传性球形红细胞增多症(HS)鉴别诊断中有重要参考价值的溶血特征。 方法: 比较1998年1月至2017年4月108例经典型PNH患者、127例AIHA患者与172例HS患者的临床表现和溶血特征。 结果: ①网织红细胞比例(Ret%):PNH患者Ret%[6.70%(0.14%~22.82%)]明显低于AIHA患者[14.00%(0.10%~55.95%),z=7.101,P<0.001]和HS患者[11.83%(0.60%~57.39%),z=8.477,P<0.001]。轻度贫血时,PNH与AIHA患者Ret%水平差异无统计学意义,AIHA患者Ret%水平低于HS患者[7.63%(1.87%~29.20%)对11.20%(3.31%~22.44%),z=-2.165,P=0.030]。中、重度贫血时,PNH患者Ret%水平均显著低于AIHA和HS患者。②总胆红素(TBIL):HS患者TBIL水平为79.3(11.2~244.0)μmol/L,显著高于AIHA患者[57.6(7.6~265.0)μmol/L]与PNH患者[26.2(4.6~217.7)μmol/L](z值分别为5.469、-2.165,P值均<0.001);HS患者TBIL超过4倍正常值上限比例(64.1%)明显高于AIHA患者(37.7%,χ(2)=19.896,P<0.001)和PNH患者(4.6%,P<0.001)。③LDH:PNH患者LDH水平为1 500(216~5 144)U/L,显著高于AIHA患者[487(29~3 516)U/L]与HS患者[252(132~663)U/L](z值分别为-9.556、-11.518,P值均<0.001);79.1%的PNH患者LDH水平>1 000 U/L,明显高于AIHA患者(13.0%,χ(2)=93.748,P<0.001)和HS患者(0,P<0.001)。④脾大:43.5%的PNH患者脾大,中、重度脾大者占16.0%;而98.6%的AIHA患者和100.0%的HS患者脾大(P<0.001),中、重度脾大者分别占63.0%(P<0.001)和90.4%(P<0.001)。⑤胆囊结石:43.1%的HS患者合并胆囊结石,明显高于AIHA患者(10.5%,P<0.001)与PNH患者(2.9%,P<0.001)。 结论: 综合评估Ret%、TBIL、LDH水平、脾大及胆囊结石这五项溶血特征,可以清晰地倾向性判断PNH、AIHA和HS,并为下一步进行特异性实验室检查确诊提供可靠的诊断思路。这种综合评估简单、实用、有效,具有重要的临床意义。.
引用
- Li WW, Shi J, Huang ZD, et al. [Comparison of hemolytic characteristics among paroxysmal nocturnal hemoglobinuria, autoimmune hemolytic anemia and hereditary spherocytosis]. Zhonghua Xue Ye Xue Za Zhi. 2018. PMID: 29779325. doi:10.3760/cma.j.issn.0253-2727.2018.04.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。